Home » Newsletters » BioWorld

BioWorld

Oct. 4, 1993

View Archived Issues

RHONE TO BUY 100% OF MERIEUX

XENOVA GAINS ACCESS TO POTENTIAL DRUG LEADS

ImmunoGen Gets Patent for Ricin

STUDY FINDS WIDER WINDOW FOR T-PA EFFECTIVENESS

RCT BUYS PICHIA EXPRESSION SYSTEM FROM PHILLIPS

ENZON FILES IND FOR GAUCHER'S DRUG

LIDAK'S LMIS WORK AS CANCER VACCINES

DURA AND DDSI COMPLETE $13M PRIVATE PLACEMENT

AVID TO COLLABORATE WITH LAMBERT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...